Isracann Biosciences Pitch Deck
5
Israeli Market
Haifa
Tel Aviv
Jerusalem
Israel
Dead Sea
Optimal climate for growing conditions will allow
Isracann to be a low-cost producer serving the domestic
market
10,000 patients on waitlist for medical cannabis due to
supply constraints
ā
Number of medical cannabis patients doubles in under
2 years (topping 70,000) despite persistent supply &
regulatory challenges. - Israeli Medical Cannabis
Agency (IMCA)
Israel indicates they will open the recreational cannabis
market in 2021. Government studies show that as many
as 27% of Israelis (aged of 18 to 65) consumed cannabis
in the last year - the highest cannabis use per capita in
the world
History of cannabis innovation and research with THC
and CBD cannabinoid structure discovered at Hebrew
University of Jerusalem
000
Access to top researchers in the field provides valuable
strategic data for the development of formulations and
cannabinoid profiles
isracann
BIOSCIENCESView entire presentation